Combination of tanshinone IIA and astragaloside IV attenuate atherosclerotic plaque vulnerability in ApoE(-/-) mice by activating PI3K/AKT signaling and suppressing TRL4/NF-κB signaling
- Resource Type
- Article
- Source
- In
Biomedicine & Pharmacotherapy March 2020 123 - Subject
- Language
- ISSN
- 0753-3322